Medical Claims Payable - Narrative (Details) $ in Millions |
Jun. 30, 2024
USD ($)
|
|---|---|
| 2022 | |
| Claims Development [Line Items] | |
| Net incurred but not reported liabilities plus expected development on reported claims | $ 452 |
| 2023 | |
| Claims Development [Line Items] | |
| Net incurred but not reported liabilities plus expected development on reported claims | 2,349 |
| 2024 | |
| Claims Development [Line Items] | |
| Net incurred but not reported liabilities plus expected development on reported claims | $ 12,254 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|